EUVIMEDEUVIMED entdecken
Crossref

Gallic acid alleviates colitis by restoring intestinal barrier function and enriching butyrate-producing bacteria

Qianyang Zhang, Chu Chu, Ning Wang, Zhengquan Xu, Yuanxiang Jin, Caihong Wang

International Immunopharmacology · 2026-06 · 179 · 116567

DOI: 10.1016/j.intimp.2026.116567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Qianyang Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Hauptthemen laut MEDLINE: Gallic Acid, Butyrates, Colitis, Ulcerative, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Institute of Natural Hazards, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC), a chronic inflammatory bowel disease, exhibits increasing global prevalence. However, there remains a paucity of evidence on whether gallic acid (GA) can be used to mitigate acute and chronic colitis. In this study, the underlying mechanism of GA in alleviating UC was thoroughly investigated. Our results showed that GA protected mice from acute and chronic colitis, evidenced by relieved pathological symptoms of UC, strengthened the tight junction, and repaired the damaged intestinal barrier. Moreover, GA regulated the balance of microbiota in the gut and increased the abundance of beneficial bacteria, especially probiotics and butyric acid-producing bacteria, such as Lachnospiraceae NK4A136. Finally, we established a co-culture model of Caco-2/RAW264.7 cells mimicking the gut barrier, GA and butyrate reduced inflammation and repaired barrier function in LPS-induced inflammation. Notably, the combined treatment of GA and butyrate showed more significant alleviation of LPS-induced inflammation and intestinal barrier damage. These findings indicated that GA effectively alleviates colitis in mice, and this effect was associated with restored intestinal barrier integrity and increased abundance of butyrate-producing bacteria. This work provides a foundation for considering GA as a potential therapeutic candidate for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gallic AcidButyratesColitis, UlcerativeGastrointestinal MicrobiomeAnti-Inflammatory AgentsColitisAnimalsIntestinal Barrier FunctionHumansCaco-2 CellsMiceRAW 264.7 CellsMaleIntestinal MucosaMice, Inbred C57BLLipopolysaccharidesColonDisease Models, Animal

Stichwörter der Autor:innen

ButyrateGallic acidIntestinal floraLPSTight junction proteinsUlcerative colitis

Substanzen

Gallic AcidButyratesAnti-Inflammatory AgentsLipopolysaccharides

Autor:innen und Institutionen

  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China.
  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Electronic address: jinyx@zjut.edu.cn.
  • College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou 310032, China. Electronic address: wangcaihong@zjut.edu.cn.

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Institute of Natural Hazards
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Q., Chu, C., Wang, N., Xu, Z., Jin, Y., & Wang, C. (2026). Gallic acid alleviates colitis by restoring intestinal barrier function and enriching butyrate-producing bacteria. International Immunopharmacology, 179, 116567. https://doi.org/10.1016/j.intimp.2026.116567

Vancouver

Zhang Q, Chu C, Wang N, Xu Z, Jin Y, Wang C. Gallic acid alleviates colitis by restoring intestinal barrier function and enriching butyrate-producing bacteria. International Immunopharmacology. 2026;179:116567. doi:10.1016/j.intimp.2026.116567

BibTeX
@article{Zhang2026,
  author = {Zhang, Qianyang and Chu, Chu and Wang, Ning and Xu, Zhengquan and Jin, Yuanxiang and Wang, Caihong},
  title = {Gallic acid alleviates colitis by restoring intestinal barrier function and enriching butyrate-producing bacteria},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {179},
  pages = {116567},
  doi = {10.1016/j.intimp.2026.116567}
}
Kostenlos starten →